Centiva Capital’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,885
Closed -$50.6K 1378
2023
Q3
$50.6K Sell
23,885
-201
-0.8% -$426 ﹤0.01% 1119
2023
Q2
$115K Buy
+24,086
New +$115K ﹤0.01% 1044
2021
Q3
Sell
-2,821
Closed -$245K 1023
2021
Q2
$245K Buy
+2,821
New +$245K 0.01% 810
2020
Q3
Sell
-11,235
Closed -$385K 593
2020
Q2
$385K Buy
+11,235
New +$385K 0.02% 221